InvestorsHub Logo
Followers 3156
Posts 961111
Boards Moderated 205
Alias Born 09/04/2000

Re: None

Monday, 10/17/2016 10:23:11 AM

Monday, October 17, 2016 10:23:11 AM

Post# of 2139
CTRV News: CMX157 Advances Head-to-Head Phase 2a Clinical Study in Hepatitis B Patients with Favorable Recommendation from DSMB 06:00 AM
CTRV News: Current Report Filing (8-k) 10/13/2016 07:13:10 AM
CTRV News: CMX157 Demonstrates 99% Viral Load Reduction in Ongoing Head-to-Head Phase 2a Clinical Study Vs. Viread® in Hepatitis B Pati... 10/13/2016 06:00:00 AM
CTRV News: Current Report Filing (8-k) 10/03/2016 08:26:21 AM
CTRV News: ContraVir to Present at the 15th Annual BIO Investor Forum 10/03/2016 06:00:00 AM
News News Alert: CMX157 Advances Head-to-Head Phase 2a Clinical Study in Hepatitis B Patients with Favorable Recommendation from DSMB 10/17/2016 06:00:00 AM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HEPA News